JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HOUS
3751
DELISTED
Anywhere Real Estate
HOUS
| $2.83M | ﹤0.01% |
856,607
-618,415
| -42% | -$2.65M |
2013 Q2
46 quarters
|
|
3752
OraSure Technologies
OSUR
$273M
| $2.83M | ﹤0.01% |
782,857
-65,076
| -8% | -$259K |
2015 Q4
36 quarters
|
|
3753
JPMorgan Equity Focus ETF
JPEF
$2.04B
| $2.82M | ﹤0.01% |
42,075
-11,042
| -21% | -$747K |
2023 Q3
5 quarters
|
|
3754
CALL
Fluor
FLR
$6.67B
| $2.81M | ﹤0.01% |
56,900
-18,100
| -24% | -$954K |
2024 Q3
1 quarter
|
|
3755
CALL
Insmed
INSM
$24.3B
| $2.8M | ﹤0.01% |
40,600
+3,800
| +10% | +$274K |
2024 Q1
3 quarters
|
|
3756
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$406M
| $2.8M | ﹤0.01% |
52,409
+49,346
| +1,611% | +$2.64M |
2023 Q4
4 quarters
|
|
3757
PUT
Hewlett Packard
HPE
$92B
| $2.8M | ﹤0.01% |
131,000
-94,000
| -42% | -$1.98M |
2022 Q1
11 quarters
|
|
3758
Transcat
TRNS
$846M
| $2.8M | ﹤0.01% |
26,434
+15,991
| +153% | +$1.77M |
2019 Q1
23 quarters
|
|
3759
Nu Skin
NUS
$224M
| $2.8M | ﹤0.01% |
405,667
+173,710
| +75% | +$1.19M |
2013 Q2
46 quarters
|
|
3760
CALL
Northern Oil and Gas
NOG
$2.54B
| $2.79M | ﹤0.01% |
75,000
| – | – |
2024 Q3
1 quarter
|
|
|
3761
PUT
Northern Oil and Gas
NOG
$2.54B
| $2.79M | ﹤0.01% |
75,000
| – | – |
2024 Q3
1 quarter
|
|
3762
WisdomTree US SmallCap Earnings Fund
EES
$689M
| $2.78M | ﹤0.01% |
51,620
-7,680
| -13% | -$421K |
2018 Q4
24 quarters
|
|
3763
Xencor
XNCR
$1.85B
| $2.78M | ﹤0.01% |
121,063
-9,291
| -7% | -$213K |
2013 Q4
44 quarters
|
|
|
IAS
3764
DELISTED
Integral Ad Science
IAS
| $2.78M | ﹤0.01% |
266,327
-451,201
| -63% | -$4.95M |
2021 Q2
14 quarters
|
|
3765
Fluence Energy
FLNC
$1.09B
| $2.77M | ﹤0.01% |
174,454
-361,730
| -67% | -$7.08M |
2021 Q4
12 quarters
|
|
|
ARR
3766
Armour Residential REIT
ARR
$1.92B
| $2.77M | ﹤0.01% |
146,706
+75,736
| +107% | +$1.45M |
2015 Q3
37 quarters
|
|
3767
Shenandoah Telecom
SHEN
$601M
| $2.77M | ﹤0.01% |
219,276
+65,426
| +43% | +$880K |
2015 Q4
36 quarters
|
|
3768
Fate Therapeutics
FATE
$278M
| $2.75M | ﹤0.01% |
1,669,562
-167,742
| -9% | -$423K |
2017 Q1
31 quarters
|
|
3769
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $2.74M | ﹤0.01% |
56,814
-2,342
| -4% | -$118K |
2016 Q4
32 quarters
|
|
|
PLGO
3770
Pelagos Insurance Capital
PLGO
$2.01B
| $2.74M | ﹤0.01% |
151,156
+37,544
| +33% | +$697K |
2023 Q3
5 quarters
|
|
3771
Global Industrial
GIC
$1.66B
| $2.73M | ﹤0.01% |
109,941
+63,936
| +139% | +$1.87M |
2016 Q4
32 quarters
|
|
3772
PUT
Middleby
MIDD
$4.73B
| $2.72M | ﹤0.01% |
20,100
| – | – |
2024 Q2
2 quarters
|
|
3773
VanEck Agribusiness ETF
MOO
$1.17B
| $2.72M | ﹤0.01% |
42,159
+8,435
| +25% | +$599K |
2017 Q4
28 quarters
|
|
3774
Lyft
LYFT
$5.85B
| $2.72M | ﹤0.01% |
210,859
-2,017,782
| -91% | -$29.9M |
2019 Q1
23 quarters
|
|
3775
iShares Morningstar Small-Cap Value ETF
ISCV
$657M
| $2.71M | ﹤0.01% |
42,750
+2,679
| +7% | +$175K |
2015 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.